1-propanol

1-propanol is a lipid of Fatty Acyls (FA) class.

Cross Reference

There are no associated biomedical information in the current reference collection.

Current reference collection contains 15712 references associated with 1-propanol in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.

Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.


Here are additional resources we collected from PubChem and MeSH for 1-propanol

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with 1-propanol

MeSH term MeSH ID Detail
Hemolysis D006461 131 associated lipids
Kidney Failure, Chronic D007676 51 associated lipids
Diabetes Mellitus D003920 90 associated lipids
Dermatitis, Contact D003877 59 associated lipids
Dermatitis, Occupational D009783 12 associated lipids
Diabetic Ketoacidosis D016883 16 associated lipids
Lupus Erythematosus, Systemic D008180 43 associated lipids
Pleurisy D010998 20 associated lipids
Kidney Neoplasms D007680 29 associated lipids
Body Weight D001835 333 associated lipids
Edema D004487 152 associated lipids
Stomach Neoplasms D013274 24 associated lipids
Abscess D000038 13 associated lipids
Carbon Tetrachloride Poisoning D002252 12 associated lipids
Hypotension D007022 41 associated lipids
Acute Kidney Injury D058186 34 associated lipids
Liver Cirrhosis, Experimental D008106 36 associated lipids
Acne Vulgaris D000152 35 associated lipids
Melanoma D008545 69 associated lipids
Occupational Diseases D009784 42 associated lipids
Brain Diseases D001927 27 associated lipids
Staphylococcal Infections D013203 15 associated lipids
Chemical and Drug Induced Liver Injury D056486 39 associated lipids
Liver Neoplasms, Experimental D008114 46 associated lipids
Drug Hypersensitivity D004342 20 associated lipids
Thalassemia D013789 8 associated lipids
Prosthesis-Related Infections D016459 7 associated lipids
Olfaction Disorders D000857 17 associated lipids
Hemoglobinopathies D006453 7 associated lipids
Sepsis D018805 11 associated lipids
Thiamine Deficiency D013832 4 associated lipids
Psoriasis D011565 47 associated lipids
Halitosis D006209 3 associated lipids
Alcoholism D000437 27 associated lipids
Starvation D013217 47 associated lipids
Meningitis D008581 5 associated lipids
Seizures D012640 87 associated lipids
Cystic Fibrosis D003550 65 associated lipids
Dermatomycoses D003881 17 associated lipids
Catalepsy D002375 30 associated lipids
Vitamin E Deficiency D014811 29 associated lipids
Urticaria D014581 13 associated lipids
Malabsorption Syndromes D008286 16 associated lipids
Necrosis D009336 4 associated lipids
Adenoma D000236 40 associated lipids
Anemia, Hypochromic D000747 5 associated lipids
Angina Pectoris D000787 27 associated lipids
Alcoholic Intoxication D000435 15 associated lipids
Photosensitivity Disorders D010787 8 associated lipids
Poisoning D011041 9 associated lipids
Drug Eruptions D003875 30 associated lipids
Blindness D001766 6 associated lipids
Eye Burns D005126 13 associated lipids
Atherosclerosis D050197 85 associated lipids
Sleep Disorders, Circadian Rhythm D020178 3 associated lipids
Syncope D013575 2 associated lipids
Neurotoxicity Syndromes D020258 34 associated lipids
Multiple Chemical Sensitivity D018777 4 associated lipids
Tick Infestations D013984 4 associated lipids
Scrapie D012608 7 associated lipids
Caliciviridae Infections D017250 2 associated lipids
Fox-Fordyce Disease D005588 2 associated lipids
Erythema Multiforme D004892 3 associated lipids
Tachycardia, Sinus D013616 2 associated lipids
Bezoars D001630 1 associated lipids
Splenic Neoplasms D013160 1 associated lipids
Hemangiosarcoma D006394 4 associated lipids
Leukemia, Plasma Cell D007952 2 associated lipids
Dysentery, Amebic D004404 3 associated lipids
Substance Abuse, Intravenous D015819 3 associated lipids
Hypokalemic Periodic Paralysis D020514 1 associated lipids
Respiratory Aspiration D053120 1 associated lipids
Per page 10 20 50 100 | Total 72

PubChem Biomolecular Interactions and Pathways

NCBI Entrez Crosslinks

All references with 1-propanol

Download all related citations
Per page 10 20 50 100 | Total 4572
Authors Title Published Journal PubMed Link
pmid:18381701
pmid:18381682
pmid:15542324
pmid:14558619
pmid:15515169
pmid:12885061
pmid:15202575
pmid:18029207
pmid:15200171
pmid:18024031
pmid:15200050
pmid:14953451
pmid:21507407
pmid:21500848
pmid:14658158
pmid:14643975
pmid:17605981
pmid:17602903
pmid:21225067
pmid:21190755
pmid:17367185
pmid:17366551
pmid:12711157
pmid:20044248
pmid:17366487
pmid:12702427
pmid:20805744
pmid:20805024
pmid:12204476
pmid:12203281
pmid:17134882
pmid:17126519
pmid:20449866
pmid:20430477
pmid:16894360
pmid:11578101
pmid:20036369
pmid:16893781
pmid:20022334
pmid:11258757
pmid:11250108
pmid:16799923
pmid:21383465
pmid:16790248
pmid:19705912
pmid:25183401
pmid:25153487
pmid:23107710
pmid:23095450
pmid:23039368
pmid:16413761
pmid:19395012
pmid:19385682
pmid:16245343
pmid:22628192
pmid:16242608
pmid:22594852
pmid:16242171
pmid:19045416
pmid:19045154
pmid:22234920
pmid:22234458
pmid:15848438
pmid:15836155
pmid:18640251
pmid:18619536
pmid:16166714
pmid:
pmid:14168427
pmid:7265921
Sapra B et al. Percutaneous permeation enhancement by terpenes: mechanistic view. 2008 AAPS J pmid:18446512
Lin SY et al. Formulation design of double-layer in the outer shell of dry-coated tablet to modulate lag time and time-controlled dissolution function: studies on micronized ethylcellulose for dosage form design (VII). 2004 AAPS J pmid:15760102
Otsuka M et al. Comparative evaluation of tableting compression behaviors by methods of internal and external lubricant addition: inhibition of enzymatic activity of trypsin preparation by using external lubricant addition during the tableting compression process. 2001 AAPS PharmSci pmid:11741271
Prodduturi S et al. Stabilization of hot-melt extrusion formulations containing solid solutions using polymer blends. 2007 AAPS PharmSciTech pmid:17622123
Kikwai L et al. In vitro and in vivo evaluation of topical formulations of spantide II. 2005 AAPS PharmSciTech pmid:16408858
Talukder R et al. Dissolution and solid-state characterization of poorly water-soluble drugs in the presence of a hydrophilic carrier. 2011 AAPS PharmSciTech pmid:21932161
Mirza S et al. Crystal morphology engineering of pharmaceutical solids: tabletting performance enhancement. 2009 AAPS PharmSciTech pmid:19184449
Siew LF et al. The potential of organic-based amylose-ethylcellulose film coatings as oral colon-specific drug delivery systems. 2000 AAPS PharmSciTech pmid:14727908
Badawi AA et al. Formulation and stability testing of itraconazole crystalline nanoparticles. 2011 AAPS PharmSciTech pmid:21706270
Sirikun W et al. Solid-State Characterization and Interconversion of Recrystallized Amodiaquine Dihydrochloride in Aliphatic Monohydric Alcohols. 2016 AAPS PharmSciTech pmid:26206402
Douroumis DD et al. Development and evaluation of cetirizine HCl taste-masked oral disintegrating tablets. 2011 AAPS PharmSciTech pmid:21181510
Tran PH et al. Design and mechanism of on-off pulsed drug release using nonenteric polymeric systems via pH modulation. 2011 AAPS PharmSciTech pmid:21161457
El-Setouhy DA et al. Formulation of a novel tianeptine sodium orodispersible film. 2010 AAPS PharmSciTech pmid:20532710
Jagdale SC et al. Formulation and evaluation of gastroretentive drug delivery system of propranolol hydrochloride. 2009 AAPS PharmSciTech pmid:19672719
Kantarci G et al. Comparison of different water/oil microemulsions containing diclofenac sodium: preparation, characterization, release rate, and skin irritation studies. 2007 AAPS PharmSciTech pmid:18181551
Gohel MC et al. Fabrication of modified release tablet formulation of metoprolol succinate using hydroxypropyl methylcellulose and xanthan gum. 2009 AAPS PharmSciTech pmid:19148762
Likovský Z et al. The effect of oxyprothepin enanthate and fluphenazine enanthate on the EEG and behaviour in rabbits. 1972 Act Nerv Super (Praha) pmid:5040160
Vinar O et al. Effects of oxyprothepin in healthy volunteers. 1972 Act Nerv Super (Praha) pmid:5040161
Dlabac A and Vanĕcek M Cardiovascular effects of the neuroleptics octoclothepin and oxyprothepin in animals. 1972 Act Nerv Super (Praha) pmid:4625133
Sýkora I Influence of long-term administration of oxyprothepin on reflexes in dogs. 1974 Act Nerv Super (Praha) pmid:4454944
Svestka J et al. Experience with oxyprothepine in the treatment of manic syndromes. 1974 Act Nerv Super (Praha) pmid:4423798
Grabe N et al. Skin disinfection before intravenous cannulation. Intraluminal contamination after disinfection with 70% isopropyl alcohol. 1985 Acta Anaesthesiol Scand pmid:4082876
Jakobsen CJ et al. A trial of povidone-iodine for prevention of contamination of intravenous cannulae. 1986 Acta Anaesthesiol Scand pmid:3776448
Virtanen P et al. Effect of splenectomy on hepasor treatment in allyl-alcohol-traumatized rat liver. 1989 Acta Anat (Basel) pmid:2741658
Savina VP et al. Simulation of space cabin atmosphere. 1979 Acta Astronaut pmid:11902168
Gazsó L and Dám A The role of water in the radiation sensitization of acetone. 1989 Acta Biochim. Biophys. Hung. pmid:2562104
Raczyñska-Bojanowska K et al. Nicotinamide dinucleotides in microorganisms producing peptide and macrolide antibiotics. 1971 Acta Biochim. Pol. pmid:4398752
Pietraszewska-Cichowicz J [Studies on the reticulocytes maturation under the influence of neurotropic drugs (author's transl)]. 1970 Acta Biol Med (Gdansk) pmid:5538239
Hilscher H et al. [Toxicity and mutagenicity of single fusel oil components on E. coli]. 1969 Acta Biol. Med. Ger. pmid:4912423
Renger F et al. [Toxic influence of the choleretics dehydrocholic acid, phenylpropanol and hydroxyphenylsalicylamide on the regenerating rat liver]. 1969 Acta Biol. Med. Ger. pmid:5375483